Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers.
Fotakis C, Megariotis G, Christodouleas D, Kritsi E, Zoumpoulakis P, Ntountaniotis D, Zervou M, Potamitis C, Hodzic A, Pabst G, Rappolt M, Mali G, Baldus J, Glaubitz C, Papadopoulos MG, Afantitis A, Melagraki G, Mavromoustakos T. Fotakis C, et al. Among authors: zoumpoulakis p. Biochim Biophys Acta. 2012 Dec;1818(12):3107-20. doi: 10.1016/j.bbamem.2012.08.009. Epub 2012 Aug 18. Biochim Biophys Acta. 2012. PMID: 22906712 Free article.
A standardized nutraceutical supplement contributes to pain relief, improves quality of life and regulates inflammation in knee osteoarthritis patients; A randomized clinical trial.
Valsamidou E, Amerikanou C, Tzavara C, Skarpas G, Mariolis-Sapsakos TD, Zoumpoulakis P, Kaliora AC. Valsamidou E, et al. Among authors: zoumpoulakis p. Heliyon. 2023 Sep 14;9(9):e20143. doi: 10.1016/j.heliyon.2023.e20143. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809749 Free PMC article.
A Randomized Controlled Trial on Pleurotus eryngii Mushrooms with Antioxidant Compounds and Vitamin D2 in Managing Metabolic Disorders.
Kleftaki SA, Amerikanou C, Gioxari A, Lantzouraki DZ, Sotiroudis G, Tsiantas K, Tsiaka T, Tagkouli D, Tzavara C, Lachouvaris L, Zervakis GI, Kalogeropoulos N, Zoumpoulakis P, Kaliora AC. Kleftaki SA, et al. Among authors: zoumpoulakis p. Antioxidants (Basel). 2022 Oct 26;11(11):2113. doi: 10.3390/antiox11112113. Antioxidants (Basel). 2022. PMID: 36358485 Free PMC article.
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists.
Roumelioti P, Polevaya L, Zoumpoulakis P, Giatas N, Mutule I, Keivish T, Zoga A, Vlahakos D, Iliodromitis E, Kremastinos D, Grdadolnik SG, Mavromoustakos T, Matsoukas J. Roumelioti P, et al. Among authors: zoumpoulakis p. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2627-33. doi: 10.1016/s0960-894x(02)00474-2. Bioorg Med Chem Lett. 2002. PMID: 12182875
Design and synthesis of novel antihypertensive drugs.
Moutevelis-Minakakis P, Gianni M, Stougiannou H, Zoumpoulakis P, Zoga A, Vlahakos AD, Iliodromitis E, Mavromoustakos T. Moutevelis-Minakakis P, et al. Among authors: zoumpoulakis p. Bioorg Med Chem Lett. 2003 May 19;13(10):1737-40. doi: 10.1016/s0960-894x(03)00251-8. Bioorg Med Chem Lett. 2003. PMID: 12729654
Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Mavromoustakos T, Zervou M, Zoumpoulakis P, Kyrikou I, Benetis NP, Polevaya L, Roumelioti P, Giatas N, Zoga A, Minakakis PM, Kolocouris A, Vlahakos D, Grdadolnik SG, Matsoukas J. Mavromoustakos T, et al. Among authors: zoumpoulakis p. Curr Top Med Chem. 2004;4(4):385-401. doi: 10.2174/1568026043451302. Curr Top Med Chem. 2004. PMID: 14965308 Review.
109 results